Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 20, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	587	157	29	35	62	61
Market Cap Growth	335.75%	434.24%	-16.81%	-42.59%	1.75%	-25.71%
Enterprise Value	589	159	27	31	61	76
Last Close Price	0.55	0.15	0.03	0.03	0.06	0.07
PE Ratio	-	7.81	8.26	3.97	12.10	-
PS Ratio	8.05	2.77	0.86	1.10	2.43	3.36
PB Ratio	12.42	2.73	1.02	1.40	3.81	5.68
P/TBV Ratio	8.82	2.74	1.03	1.43	3.92	-
P/FCF Ratio	227.16	-	-	5.88	21.50	-
P/OCF Ratio	97.17	-	8.81	5.43	19.27	-
EV/Sales Ratio	8.28	2.81	0.80	0.96	2.40	4.25
EV/EBITDA Ratio	36.13	13.14	5.25	4.94	17.86	-
EV/EBIT Ratio	40.32	14.75	6.92	6.11	28.90	-
EV/FCF Ratio	227.87	-	-	5.15	21.24	-
Debt / Equity Ratio	0.24	0.20	0.13	0.11	0.15	0.38
Debt / EBITDA Ratio	0.70	0.96	0.73	0.43	0.66	-
Debt / FCF Ratio	4.41	-	-	0.46	0.83	-
Asset Turnover	0.90	0.91	0.90	1.05	0.99	0.73
Inventory Turnover	2.68	2.69	2.16	2.97	2.95	2.31
Quick Ratio	2.41	2.04	1.39	1.73	1.15	0.61
Current Ratio	3.52	3.07	2.75	2.82	2.10	1.19
Return on Equity (ROE)	-13.83%	46.47%	13.15%	43.01%	37.96%	-20.32%
Return on Assets (ROA)	11.49%	10.83%	6.52%	10.33%	5.14%	-5.79%
Return on Capital (ROIC)	16.39%	13.20%	8.15%	13.62%	7.92%	-9.50%
Earnings Yield	-1.84%	12.80%	12.11%	25.18%	8.27%	-3.70%
FCF Yield	0.44%	-2.60%	-8.16%	17.00%	4.65%	-3.02%
Buyback Yield / Dilution	-2.67%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%
Total Shareholder Return	-2.67%	-1.02%	-0.23%	-7.17%	5.06%	-21.68%

Source: S&P Capital IQ. Standard template. Financial Sources.